Literature DB >> 718274

SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation.

R P Yeatts, R Turner, R Collins, J Kaufmann, H Mashburn.   

Abstract

The interactions of soluble and insoluble immunoglobulin G (IgG) complexes with macromolecular rheumatoid factor (RF) and platelets were examined in an in vitro system permitting observation of platelet activities which may contribute to rheumatoid inflammation. Studies of the aggregation phenomenon by the nephalometric technique and by selective sedimentation of 51Cr-labelled platelets revealed no aggregation by platelets exposed to heat aggregated IgG (HAIgG) complexes or their RF precipitates in a plasma test system. Release of serotonin was demonstrated by the increasing radioactivity of platelet supernates to 45 min by 14C-serotonin labelled platelets exposed to insoluble IgG heat aggregates. Significantly less release was shown with saline, native IgG, and soluble IgG complexes. When RF was added to soluble HAIgG complexes, the resulting precipitate caused significantly higher release than controls. No concomitant release of the lysosomal enzyme beta-glucuronidase was detected. Thus, although soluble complexes do not cause significant release of biologically active amines, conversion of soluble complexes to insoluble immune precipitates by RF is associated with this activity which is independent of platelet aggregation and/or lyosomal enzyme release in our test system. Release of biologically active amines from platelets exposed to insoluble complexes may be important in the initiation and propagation of inflammation in rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 718274      PMCID: PMC1000269          DOI: 10.1136/ard.37.5.421

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  THE AGGREGATION OF BLOOD PLATELETS.

Authors:  G V BORN; M J CROSS
Journal:  J Physiol       Date:  1963-08       Impact factor: 5.182

2.  Aggregation of human blood platelets by unrelated antigen-antibody reaction: sequence of reaction and role of complement.

Authors:  G Myllylä
Journal:  Ann Med Exp Biol Fenn       Date:  1973

3.  Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors:  K Hannestad
Journal:  Clin Exp Immunol       Date:  1967-07       Impact factor: 4.330

4.  Inhibition of collagen-induced platelet aggregation by normal plasma.

Authors:  H L Nossel; G D Wilner; M Drillings
Journal:  J Clin Invest       Date:  1971-10       Impact factor: 14.808

Review 5.  The effects of immune complexes on blood platelets and their relationship to complement activation.

Authors:  S L Pfueller; E F Lüscher
Journal:  Immunochemistry       Date:  1972-11

6.  Characterization of IgG complexes in eluates from rheumatoid tissue.

Authors:  E Munthe; J B Natvig
Journal:  Clin Exp Immunol       Date:  1971-02       Impact factor: 4.330

7.  Release of elastolytic activity from blood platelets.

Authors:  B Robert; M Szigeti; L Robert; Y Legrand; G Pignaud; J Caen
Journal:  Nature       Date:  1970-09-19       Impact factor: 49.962

8.  Gamma globulin complexes in rheumatoid arthritis and hypergammaglobulinemic purpura.

Authors:  R A Clark; G N Abraham; R Kyle; J H Vaughan
Journal:  J Rheumatol       Date:  1974-03       Impact factor: 4.666

9.  The release of nucleotides, 5-hydroxytryptamine and enzymes from human blood platelets during aggregation.

Authors:  D C Mills; I A Robb; G C Roberts
Journal:  J Physiol       Date:  1968-04       Impact factor: 5.182

10.  The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces.

Authors:  W T Kniker; C G Cochrane
Journal:  J Exp Med       Date:  1968-01-01       Impact factor: 14.307

View more
  7 in total

1.  Long-term low dose ticlopidine treatment in rheumatoid arthritis: effects on serum sulphydryl levels, technetium index, erythrocyte sedimentation rate, and clinical disease activity.

Authors:  M G Grimaldi
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

2.  Long-term low dose haloperidol treatment in rheumatoid patients: effects on serum sulphydryl levels, technetium index, ESR, and clinical response.

Authors:  M G Grimaldi
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

3.  Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis.

Authors:  G K Endresen
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

4.  Investigations on vitamin E and lipid peroxide status in rheumatic diseases.

Authors:  M Mezes; G Bartosiewicz
Journal:  Clin Rheumatol       Date:  1983-09       Impact factor: 2.980

5.  Platelets in the synovial fluid of patients with rheumatoid arthritis.

Authors:  M Farr; A Wainwright; M Salmon; C A Hollywell; P A Bacon
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

6.  Interaction of human platelets with particle-adherent aggregated IgG: description of the experimental system and role of C1q and monomeric IgG.

Authors:  R S Vollertsen; F C McDuffie; E J Bowie
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

7.  Platelets as target cells in rheumatoid arthritis and systemic lupus erythematosus: a platelet specific immunoglobulin inducing the release reaction.

Authors:  E Weissbarth; B Baruth; H Mielke; W Liman; H Deicher
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.